Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-07 4:12 pm | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 17,948 | $5 | $89,740 | 14,328 (Direct) | View |
| 2026-10-01 Sale | 2026-10-07 4:11 pm | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 48,081 | $5 | $240,405 | 111,882 (Direct) | View |
| 2026-10-01 Sale | 2026-10-07 4:09 pm | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 17,142 | $5 | $85,710 | 13,683 (Direct) | View |
| 2026-10-01 Sale | 2026-10-07 4:09 pm | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 24,655 | $5 | $123,275 | 47,682 (Direct) | View |
| 2026-10-01 Sale | 2026-10-05 9:00 pm | Arbutus Biopharma Corp | ABUS | Roivant Sciences Ltd. Director 10% Owner | 8,967,383 | $5 | $44,836,915 | 29,880,079 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:02 pm | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 22,183 | $3.283 | $72,827 | 159,724 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:02 pm | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 19,348 | $3.283 | $63,519 | 106,194 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:02 pm | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 23,790 | $3.283 | $78,103 | 1,481,003 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:02 pm | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 11,333 | $3.283 | $37,206 | 86,244 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:07 pm | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 8,846 | $3.6895 | $32,637 | 46,069 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 10,456 | $4.39 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 116,408 | $3.2 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 126,864 | $0 | 327,595 (Direct) | View |
| 2026-09-18 Tax Withholding | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 82,527 | $5.07 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 265,625 | $3.49 | 805,263 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 27,475 | $4.39 | 805,263 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A 2035-03-31 | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 293,100 | $0 | 805,263 (Direct) | View |
| 2026-09-18 Tax Withholding | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 206,637 | $5.07 | 805,263 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 52,533 | $3.34 | 135,892 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A 2035-08-04 | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 131,333 | $0 | 135,892 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 78,800 | $4.24 | 135,892 (Direct) | View |
| 2026-09-18 Tax Withholding | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 100,508 | $5.07 | 135,892 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 52,533 | $3.2 | 137,343 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 131,333 | $0 | 137,343 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 78,800 | $4.24 | 137,343 (Direct) | View |
| 2026-09-18 Tax Withholding | 2026-09-23 8:31 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 99,057 | $5.07 | 137,343 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:05 pm | 2026-06-08 2036-06-08 | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 78,800 | $0 | 78,800 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:05 pm | 2026-06-08 2036-06-08 | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 78,800 | $0 | 78,800 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-02 8:21 pm | N/A 2036-02-02 | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 261,900 | $0 | 261,900 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-02 8:21 pm | N/A 2036-02-02 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 99,700 | $0 | 99,700 (Direct) | View |
| 2025-08-04 Option Award | 2025-08-06 4:08 pm | N/A 2035-08-04 | Arbutus Biopharma Corp | ABUS | Sawhney Roger Director | 157,600 | $0 | 157,600 (Direct) | View |
| 2025-03-31 Option Award(A) | 2025-04-01 5:47 pm | N/A 2035-03-31 | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2025-03-31 Option Award | 2025-03-31 4:24 pm | N/A 2035-03-31 | Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2025-03-18 Option Award | 2025-03-20 4:14 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Hasija Anuj Director | 157,600 | $0 | 157,600 (Direct) | View |
| 2025-03-18 Option Award | 2025-03-20 4:10 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director | 157,600 | $0 | 157,600 (Direct) | View |
| 2025-03-18 Option Award | 2025-03-20 4:08 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 310,422 | $0 | 310,422 (Direct) | View |
Ownership | 2025-03-06 4:07 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Gline Matthew Director 10% Owner | 0 | $0 | 38,847,462 (Indirect) | View |
| 2025-02-14 Option Award | 2025-02-19 6:25 pm | N/A 2035-02-14 | Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO | 274,600 | $0 | 360,844 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 6:25 pm | N/A 2035-02-14 | Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO | 895,800 | $0 | 2,376,803 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 6:25 pm | N/A 2035-02-14 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 455,900 | $0 | 615,624 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 6:25 pm | N/A 2035-02-14 | Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer | 249,600 | $0 | 355,794 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0.56 | 46,069 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A 2024-11-13 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0 | 46,069 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:17 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:16 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:14 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:12 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Meyers James R Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:10 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | Rewolinski Melissa Director | 67,000 | $0 | 67,000 (Direct) | View |